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Brassinosterols (BS) are ubiquitous pluripotent growth regulator 
present in plants. They exist in isoforms of epi and 
homobrassinolides (HB).  BS act as potent stimulators of root and 
shoot elongation, cell division, DNA and RNA polymerase activity, 
ethylene production and of stress tolerance to temperature, water 
scarcity and salinity in plants. It is also used to increase the yield of 
crop and to protect the plants against pesticides. Consumption of 
plant material as diet and used as growth regulator in animals, and 
application of BS in agriculture would increases its availability to the 
host tissues. In the present study, the effect of 28-HB, an isomer of 
brassinosterol on serum, liver and kidney marker enzymes, lipid 
peroxidation, tissue histology and the blood parameters of rat were 
investigated. The rats were given the compound by intradermal 
mode at the concentration of 75µg, 150µg and 300µg as single dose 
and the effects were observed after 4 hr to study the immediate 
response of the animal.   
The treatment of rats with 28-HB, caused different effects on the 
serum, liver and kidney parameters of this study.   
In conclusion, the present study showed that 28-HB affects the 
structure and function of rat tissues in a dose dependent manner. 
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Introduction 
The use of plant growth regulators (PGRs) in 
agriculture for raising plant food production 
employing a wide variety of crops is increasing 
at a steady rate.  The amount of these substances 
deposited into the environment may soon 
exceed those of insecticides (1).  Hence, the 
probability of assimilating PGRs from 
environment, plant derived foods and traditional 
medicine into animal tissues including human is 
significant.  Although many studies have been 
conducted on the effect of PGRs on animal cell 
metabolism, there is no study on the effect of 
28-HB on animal cell metabolism. The present 
study therefore, aims to investigate the 
immediate effects of 28-HB at different doses 
on male albino rats by estimating the activities 
of selected metabolic marker enzymes like 
Aspartate transaminase(AST), Alanine 
transaminase(ALT), Acid phosphatase (ACP), 
Alkaline phosphatase(ALP), Gamma glutamyl 
transpeptidase(GGT) amylase(AMY), 
Hexokinase (HK) and certain biochemical 
parameters and histological changes in  liver, 
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28-Homobrassinolide (28-HB) is a naturally 
occurring polyhydroxy steroid lactone growth 
regulator with pleiotropic effects in plants (2). It 
is an ubiquitous hormone in the plant  kingdom 
and  plays an important  role in  cellular 
processes such as anti stress activity,  seed 
germination, flowering, senescence, abscission, 
maturation  in  plants and for protection of 
plants against  environmental stress (3). The 
studies of Guarra (4), Visscher (5), Visscher (6), 
De man et al. (7) and Alonso (8) reported that 
the fecundity, longevity and egg viability of 
insects were changed by PGR treatment.  Olson 
et al. (9) reported that the PGRs caused an 
increase in the number of splenic plaque 
forming cells, circulating  WBCs,  hematocrit  
values,  and  thymus  weight  in  young  deer  
mice. 
 
Celik.I et al. (10) reported that some PGR 
affects the oxidative defense system and MDA 
content in rats.  Lipid peroxidation is one of the 
molecular mechanisms of PGRs induced 
toxicity (11). Oxidative stress produces DNA 
damage, enzyme inactivation and lipid 
peroxidation of cell constituents, especially 
when antioxidant defenses were impaired or 
overcome (12).  John et al (13) reported that the 
gibberellic acid (GA3) induce liver neoplasm in 
Egyptian toads.  Sexual differentiation and 
physiological parameters of mice was affected 
by GA3 and Abscissic acid (14). Alteration of 
hematological and biochemical parameters of 
rats treated with indole acetic acid and kinetin 
was also reported by Celik et al (15). Indole 
acetic acid (IAA) was found to inhibit AST and 
activate amylase in rats, whereas it activated 
AST and ALT in human blood serum (16). The 
levels of marker enzymes in tissues and 
biological fluids may get altered following 
administration of foreign agents and that such 
alterations could be used to assess the metabolic 
assault induced in the tissue of rat. It has been 
shown, that hexokinase gene expression is a 
realistic possibility employing 28-HB as the 
effector molecule during in vivo studies in rats 
(17).    
 
Though there are several research reports 
available on the effect of PGR on animal cell 
metabolism, the study on the immediate effects 
of 28-HB on animal cell function is absent.  
Therefore, this study is of important and unique 
in view of mode of entry, duration and organs 
structure and toxicity relationships on selected 
parameters.  Acute and short term toxicity study 
and toxicological evaluation using experimental 
animals should be done in all preparations 
marketed for medicinal use (18). 
 
Materials And Methods 
Materials 
28-Homobrassinolide was a gift from Dr.Vyas 
Godrej Agrovet Chemicals Ltd., Mumbai, India.   
All chemicals used for this study were of 
analytical grade purchased from manufacturers 
in India.  Glass distilled water was used for the 
preparations of all reagents. 
 
Animals 
Male albino wistar strain rat in the weight range 
160-180g (10-12 weeks old) were obtained from 
JIPMER, Puducherry, India. The rats were 
housed   at 20±2°C in a daily light/dark cycle.  
All rats were fed Kamadhenu (India) rat feed 
pellet (composition analysed and established) 
and were given water ad libitum.  The care of 
rats was as per the `Guide for the care and use 
of Laboratory Animals’ during experiments. 
 
Treatment of rats 
The rats were housed in 4 groups of 6 each.  A 
control group was given 50µl of 50% absolute 
alcohol subcutaneously to serve as control. The 
experimental group of rats was given 28-HB in 
50µl of alcohol subcutaneously in a single dose 
at the dose levels of 75µg, 150µg and 300µg/kg 
body weight. 4 hours following the treatment, 
the rats were anaesthetized with anesthetics 
ether.   Blood samples were collected by cardiac 
puncture.  Blood samples were allowed to clot 




and were centrifuged for the preparation of 
serum used for biochemical analysis. Selected 
tissues of the rat were surgically removed and 
immediately rinsed in ice cold physiological 
saline.  The tissues were initially cut into small 
pieces and taken for homogenization employing 
several stroke in a potter-Elvehjem homogenizer 
using a Teflon pestle to obtain 10% W/V tissue 
homogenate in 1.15% KCl solution. Throughout 
the homogenization process, the tissue 
homogenates were maintained on crushed ice 
and then centrifuged at 10,000xg for 10 minutes 
in a refrigerated Hitachi high speed centrifuge at 
4°C.  Supernatant and serum obtained were used 
for biochemical analysis. 
 
Measurement of enzyme activities 
AST and ALT was assayed by the method of 
Reitman and Frankel (19). ACP was assayed by 
the method of Tennis wood et al (20).  ALP was 
assayed by the method of Bessey et al (21). 
GGT activity was measured by Orlowski and 
Meister (22).  Amylase activity was assayed by 
the method of Bernfeld (23) and the Hexokinase 
activity was measured by the standard method 
(24).                                 
 
Biochemical analysis  
Glucose content was measured by the modified 
procedure of Asatoor and King method (25).  
Cholesterol content was measured by the 
modified method of Zak et al (26). Triglyceride 
content was measured by the method of Gruddy 
and Benjamin (27). The serum quantitative 
colorimetric determination of LDL, HDL and 
VLDL level was done using EnzyChromTM 
HDL and LDL/VLDL Assay Kit (EHDL-100). 
Protein content was measured by the method of 
Lowry et al. (28). The quantity of albumin was 
measured by the method of Reinhold (29). Urea 
content was measured by the method of 
Netelson et al. (30).  The content of uric acid 
was measured by the method of Caraway (31).  
The end product of lipid peroxidation, 
thiobarbutric acid reactive substance (TBARS) 
as MDA, was measured by the method of 
Nichens and Samuelson (32).      
 
Analysis of data 
The data was expressed as mean ± Standard 
Error Mean (SEM) for six rats.  SPSS program 
was used for statistical analysis. The difference 
between the control and treated values was  
found  using  one way ANOVA and the  
significance was  noted  at  p<0.05*  and  
p<0.01** levels for all the tests.    
 
Results 
The results of the present study showed that the 
treatment of rat with 28-HB caused changes in 
the specific activities of metabolic marker 
enzymes (Table-1), concentration of biomarkers 
(Table-2) in serum, liver and kidney and 
histological architecture (Figure1-8) in dose 
dependent manner. A 19% decrease and 12% 
increase in serum AST activity was observed, 
respectively at 150 and 300µg of treatment 
without any significant change in liver and 
kidney.  An increment in the activity of ALT 
was noted in serum at 75µg 28-HB treatment 
alone.  On the other hand, the activities of ACP, 
ALP, GGT, amylase and hexokinase were 
significantly increased in liver at 150 and 300µg 
doses after 4 hrs of treatment.  There was a 
significant decrease in ALP activity was noted 
in serum for all the doses of 28-HB treatment 
against the corresponding control rats for the 
same period.  In contrast, the activities of 
amylase and hexokinase were significantly 
increased in serum, liver and kidney irrespective 
of the dose. 
 
Analysis of serum parameters showed a 
significant reduction (37-41%) in serum glucose 
level for all the doses of 28-HB.  The rat liver 
tissue cholesterol content was reduced 
quantitatively by 28-HB (20-27%).  In contrast, 
the serum and kidney cholesterol content was 
increased (14%) for all the dose of 28-HB.  
 





                                                
                    Control liver showing                                         75µg of 28-HB treated rat liver  
                    normal architecture                                          showing congestion of central vein 









150µg of 28-HB treated rat liver                              300µg of 28-HB treated rat liver 
           showing congestion of central vein                          showing congestion of central vein and     
           loss of blood cells                                                      and loss of blood cells                     
Fig. 1:  Section through liver of rat 4 hr following 28-HB administration (H & E x 40). 
 
 
              
            Control kidney showing                     75µg of 28-HB treated rat kidney              
             normal architecture                           showing moderate tubular dilation   
 
                                  
150µg of 28-HB treated rat kidney         300µg of 28-HB treated rat kidney 
  showing moderate tubular dilation           showing high tubular dilation  
Fig 2: Section through kidney of rat 4 hr following 28-HB administration (H & E x 40). 
 




Table 1: Effect of  28-Homobrassinolide on the metabolic marker enzymes of  serum, liver and kidney in male rat. 
 
Tissues  Enzymes     Control            28-homobrassinolide (µg/kg body wt.)                                   
                                                                           75µg                        150µg                     300µg                
Serum         AST            3.39 ± 0.159           2.75 ± 0.160             3.41 ± 0.121           3.78 ± 0.182* 
                    ALT     0.94 ± 0.063          0.73 ± 0.022**         0.90 ± 0.043           0.94 ± 0.035 
                    ALP               6.48 ± 0.380           3.82 ± 0.133**         4.15 ± 0.238**       4.90 ± 0.205** 
                    GGT             0.101 ± 0.007         0.063 ± 0.004**       0.062 ± 0.003**     0.086 ± 0.003* 
                    AMY            10.42 ± 0.233         10.48 ± 0.220           11.82 ± 0.409*       12.47 ± 0.515*   
Liver           AST               4.88 ± 0.217           4.77 ± 0.247             4.97 ± 0.280           4.95 ± 0.270 
                    ALT               8.16 ± 0.580           8.07 ± 0.680             8.08 ± 0.613            8.10 ± 0.370   
                    ACP               8.32 ± 0.615           8.28 ± 0.537             9.45 ± 0.399*         10.20 ± 0.453** 
                    ALP               4.04 ± 0.376           4.42 ± 0.171             4.50 ± 0.254            4.68 ± 0.121* 
                    GGT              7.44  ± 0.480       7.94 ± 0.550             10.37 ± 0.401**     11.93 ± 0.520** 
                    AMY              4.29 ± 0.168           4.34 ± 0.177             5.15 ± 0.160*          5.50 ± 0.110* 
                    HK                 1.42 ± 0.082           1.98 ± 0.106**         2.16 ± 0.128**        1.76 ± 0.063** 
 Kidney       AST        2.63 ± 0.092          2.23 ± 0.102*           2.24 ± 0.102*          2.57 ± 0.201 
                    ALT               3.26 ± 0.220      3.12 ± 0.145            3.00 ± 0.100            3.27 ± 0.108   
                    ACP               5.61 ± 0.307           4.51 ± 0.204*            4.99 ± 0.200           5.18 ± 0.311 
                    ALP               33.8 ± 1.450          41.4 ± 2.17**            42.5 ± 1.90**         46.6 ± 2.07** 
                    GGT              257.0 ± 11.30         228.0 ± 11.4              231.0 ± 7.10           242.0 ± 12.4    
                    AMY              2.40 ± 0.135           3.81 ± 0.169**         4.09 ± 0.180**       4.19 ± 0.207** 
                    HK                 1.22 ± 0.072           1.62 ± 0.099**         1.92 ± 0.121**       1.67 ± 0.092** 
p<0.05*, p<0.01** 
Serum enzyme activities were expressed as IU/mg protein x 10-3 
Tissue enzyme activities were expressed as IU/mg protein/gm tissue x 10-2 
 
Table 2:  Effect of 28-homobrassinolide on serum, liver and kidney biochemical parameters of male rats. 
Tissues     Parameters            Control                     28-Homobrassinolide (µg/kg body wt)                                     
                                                       75µg                   150µg                   300µg                 
Serum      Glucose(mg/dl)       110.0 ± 6.73        65.0 ± 2.11**        69.0 ± 3.18**        70.0 ± 3.61** 
                 TC(mg/dl)               78.0 ± 4.44           84.0 ± 4.92       86.0 ± 3.46             89.0 ± 4.49* 
                 TG(mg/dl)               56.0 ± 3.92          58.0 ± 3.64             60.0 ± 5.04            62.0 ± 3.02 
                 HDL(mg/dl)            17.1 ± 0.69          22.1 ± 1.03**         22.3 ± 1.06**         22.1 ± 1.11** 
                 LDL(mg/dl)             39.0 ± 1.12          46.0 ± 2.04*           46.0 ± 2.69*          48.0 ± 2.04**   
                 VLDL(mg/dl)          22.1 ± 1.21          16.2 ± 0.92**         16.3 ± 0.74**        21.2 ± 1.02 
                 Protein(g/dl)            6.00 ± 0.444        6.20 ± 0.411           6.10 ± 0.553          6.00 ± 0.567 
                 Albumin(g/dl)         3.60 ± 0.21           4.00 ± 0.139*         3.90 ± 0.29            3.90 ± 0.20 
                 Urea (mg/dl)            33.0 ± 1.38        30.0 ± 2.83    29.0 ± 1.06*     23.0 ± 1.09** 
                 Uric acid(mg/dl)      9.70 ± 0.687        9.50 ± 0.516           10.60 ± 0.475        11.20 ± 0.404*   
Liver        TC(mg/gm)             4.50 ± 0.381         3.30 ± 0.165**       3.40 ± 0.111**      3.60 ± 0.168** 
          TG(mg/gm)           1.30 ± 0.173         0.80 ± 0.045**       0.80 ± 0.032** 0.80 ± 0.033** 
  Protein(mg/gm)    150.0 ± 9.97         150.0 ± 9.09           150.0 ± 11.1          150.0 ± 7.41 
 Albumin(g/gm)      30.0 ± 2.70          40.0 ± 2.27**        30.0 ± 1.29            30.0 ± 2.78 
 Urea (mg/gm)        1.95 ± 0.214        1.89 ± 0.074           1.99 ± 0.138          2.60 ± 0.133** 
 Uric acid(mg/gm)  1.21 ± 0.057        1.25 ± 0.061           1.25 ± 0.051          1.47 ± 0.058* 
 MDA (nmol/mg     1.45 ± 0.060        1.74 ± 0.071**       1.82 ± 0.070**      1.91 ± 0.040** 
 of protein) 
 





Kidney       TC(mg/gm)            5.22 ± 0.317       4.50 ± 0.169           5.47 ± 0.365        5.47 ± 0.415 
 TG(mg/gm)            1.90 ± 0.145       2.50 ± 0.112**       2.70 ± 0.129**    2.80 ± 0.100** 
 Protein(mg/gm)     100.0 ± 7.73       112.0 ± 7.28           110.0 ± 6.62        100.0 ± 8.32 
 Albumin(g/gm)       31.0 ± 2.27         52.0 ± 1.90**        51.0 ± 1.86**       36.0 ± 1.84* 
 Urea (mg/gm)         5.30 ± 0.441       6.50 ± 0.203**       6.60 ± 0.309**    7.00 ± 0.263** 
 Uric acid(mg/gm)   2.29 ± 0.139       2.34 ± 0.099           2.35 ± 0.161        2.50 ± 0.110 
 MDA (nmol/mg      1.52 ± 0.105       2.06 ± 0.086**       2.08 ± 0.073**     2.10 ± 0.076** 
 of protein) 
  
      p<0.05*, p<0.01**  
 
 
The content of triglyceride reduced in liver for 
all dose (20-27%), but showed elevation in 
kidney for all dose and in serum for 300µg 28-
HB alone.  A significant increase in HDL (29%) 
and LDL (18-23%), and decrease in VLDL (4-
27%) was observed in serum in a dose 
dependent manner.  28-HB does not produced 
any remarkable changes in protein and albumin 
content of serum and liver, with significant 
depletion (65-68%) in kidney albumin content 
only. 
 
The quantity of urea was significantly decreased 
(12-30%) in serum and increased (23-32%) in 
kidney at all dose treatment.  While, the uric 
acid content was significantly improved in 
serum, liver and kidney at 300µg dose.  MDA, 
the end product of lipid peroxidation was 
significantly elevated in liver (20-31%) and the 
kidney (36-38%) in a dose dependent manner.  
The figure 1-8 shows the histological structure 
of the liver and kidney of a control and 28-HB 
treated rat tissue.  Examination of liver of rat 
after 4 hr of treatment with 28-HB, showed a 
degenerative changes in hepatocytes such as 
cytoplasmic vacuolation and mild congestion of 
central and portal veins.  The examination of the 
kidney of rats after the same period of treatment 
showed moderate tubular dilation and other 
alterations.   
 
Discussion 
The effect of human health of chemicals that are 
modified through the endocrine system has 
generated huge interest and investment. It has 
also been recognized that endocrine active 
substances are potentially present in food as 
natural compounds (33).  The present study is 
therefore, directed to understand the short-term 
effect of a brassinosteroid isoform, 28-
homobrassinolide, whose positive/negative 
effects on higher animals, remains unknown, 
when it was exposed in higher doses. The data 
collected in this study relates to experiments 
carried out for a single time point, but using 
different doses. Till date no study had been 
conducted to investigate the short term influence 
of 28-HB in vivo on rat serum, tissue marker 
enzyme activities, biomarkers and on their 
MDA content and their histological changes. 
Therefore, the present result could not be 
compared with the previous results. The 
measurement of the activities of the various 
enzymes in the animal tissues and body fluids 
plays a critical role in disease investigation and 
diagnosis and also for the identification of drug 
toxicity including that of natural compounds 
(34). 
 
Treatment of rat with 28-HB induced an up and 
down regulation in the activities of AST and 
ALT in serum, liver and kidney in a dose 
dependent manner.  These changes may 
possibly due to the imbalance in an amino acid 
metabolism (transamination) by this compound 
in an animal system. ALP activity also 
decreased remarkably in serum and increased in 
liver and kidney. Such an increase in liver and 
kidney ALP activity may due to the induction of 
synthesis of this enzyme in liver and kidney by 




28-HB.  It may also be due to a reduction in 
concentration or total absence of specific 
phospholipids required by this membrane bound 
enzyme to express its full activity in liver (34). 
A mixed response was noted for the GGT 
activity showing reduction trend in serum and 
kidney in a dose dependent manner.  It indicates 
that 28-HB affected the kidney alone by altering 
its glutamate metabolism and amino acid 
absorption. Taken together with the changes in 
the AST and ALT specific activity levels 
observed in the rat serum and liver and the 
changes in GGT activity pointed to a possible 
hepato-biliary disturbance (35) and myocardial 
infraction like symptoms in the experimental 
rats.  In contrast, the amylase activity was 
elevated in all tissues for all doses of 28-HB. 
Although no specific reasons for such changes 
are clearly understood, it possible that 28-HB 
exerted effect similar to other 
pesticides/xenobiotics causing structural 
damage to membranes and protein leakage in 
cells.  The effect of  28-HB on rat on the other 
hand is similar to of the effect of analgesics on 
the sphincter of Oddi, causing spasmodic 
contraction of this muscular wall resulting in 
impedance of bile and other juice.  Hexokinase 
activity was also found to increase 28-HB at all 
dose in liver and kidney in a dose dependent 
pattern.  This may be to increase the rate of 
glucose metabolism (glycolysis). Serum 
enzymes are generally derived from tissues 
through extrusion and damage to cell 
membranes (36).  Increase in the hexokinase 
enzyme specific activity encountered during the 
study was also statistically significant, and had 
an important bearing on the physiology of the 
animal. Since, hexokinase is primarily an 
enzyme that phosphorylated circulating free 
glucose that entered the cells, increased activity 
of this enzyme induced by 28-HB points to the 
greater phosphorylation potential that developed 
in an animal cell causing it to utilize the cellular 
glucose at greater rates, thereby regulating 
glucose homeostasis in normal rats. It has been 
reported that 28-HB was capable of inducing 
hexokinase mRNA expression in rat tissues 
when administered orally. 
 
28-HB treatment of rat resulted in a significant 
reduction in serum glucose.  The exact 
mechanism for such a decrease of glucose is not 
known clearly. But it may be possibly due to the 
enhanced glucose metabolism as a result of the 
28-HB effect on animal cells. Plant products 
may act on blood glucose through different 
mechanisms. Some of them may have insulin-
like substances.  Decreased blood glucose has 
been reported following consumption of some 
plant extracts (37).  
 
Decrease in liver cholesterol content was 
observed following 28-HB treatment without 
any significant change in serum and kidney 
tissues. Cholesterol is seen generally increased 
in liver diseases and contributed to the disease 
of arthrosclerosis, when deposited within the 
arterial endothelium. An increase in cholesterol 
level is a sign of liver damage.  The level of 
triglycerides in serum and kidney was increased. 
Serum triglyceride level is a biomarker to asses 
the risk of cardiovascular diseases in man.  
Elevated triglycerides levels were indicative of 
high risk and can be due to obesity as well as 
drugs such as β-blockers, retinoids, estrogens 
and cholesteramine. A significant increase in 
HDL (29%) and LDL (18-23%), and decrease in 
VLDL (4-27%) was observed in a dose 
dependent manner without any increment in the 
HDL/LDL ratio.  Cholesterol and LDL are 
important lipids associated with cardiovascular 
diseases.  Plasma VLDL + LDL- cholesterol 
represent mobilization of fats from the liver to 
adipose tissue. LDL carries 60%-70% of the 
total cholesterol in the serum and also VLDL is 
the main carrier of triglycerides.  High 
HDL/LDL ratios are associated with a decreased 
risk of vascular diseases (38).  
 
Treatment of rat with 28-HB increased the 
content of albumin in kidney. It is therefore 
probable that the kidney albumin fractions 





increased as a result of the plant hormone 
impact.   The content of urea was increased in 
serum, liver and kidney for 75µg 28-HB.  
Elevation of urea content in serum, liver and 
kidney of 28-HB treated rats is considered to be 
an indicator of haemo, hepato and 
nephrotoxicity. Altered serum urea level noted 
in the experimental rat in the present study 
possibly indicated influence of 28-HB on the 
tissue urea cycle. Higher blood urea or NH3 
concentration was considered as an indication of 
urinary obstruction or hepatic dysfunction (39). 
 
Our results also indicate that 28-HB affected 
MDA content in the liver and kidney tissues of 
rats.  MDA is a major oxidation product of 
peroxidised fatty acids as an indicator of lipid 
peroxidation.  MDA content was significantly 
increased in liver and kidney at all of 28-HB. 
These results were in agreement with the earlier 
reports from this laboratory. The observed 
histological changes in the liver and kidney of 
28-HB treated rats’ shows that this compound is 
capable of altering the histology of rats in a dose 
dependent manner. These changes were similar 
to the earlier reports though the compounds are 
different.  GA3 has been reported to induce 
micro abscesses and hydropic degeneration in 
the liver, while causing nuclear inflammatory 
infiltration in the kidney of mice and in the liver 
of rat.  Moreover, gibberellin A3 also has been 
reported to induce breast and lung adenoma in 
mice. Feeding of chicken with GA3 led to 
numerous histological lesions in different 
organs including liver, but returned to normal 
following withdrawal (40).  
 
In conclusion, these 
results suggest that the 28-HB having the 
potential to modulate the metabolism of rats like 
other PGRs, pesticides and xenobiotics by 
altering different enzymes, MDA, and 
biomarkers and histology which is being 
evidenced by this study. Judicial use of the 
natural products is necessary though it is a 
component of natural origin.   
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